Cyclerion Therapeutics (CYCN) Change in Cash (2019 - 2025)

Cyclerion Therapeutics' Change in Cash history runs 7 years deep, the most recent figure standing at $1.6 million for Q3 2025.

• In Q3 2025, Change in Cash rose 191.03% year-over-year to $1.6 million; the TTM figure through Sep 2025 stood at $1.7 million (up 127.2% YoY), while the FY2024 annual figure was -$4.3 million, up 25.33% from the prior year.
• Change in Cash was $1.6 million for Q3 2025 at Cyclerion Therapeutics, up from -$633000.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $25.1 million in Q2 2021 to a low of -$13.0 million in Q1 2021.
• Historically, Change in Cash has averaged -$2.8 million across 5 years, with a median of -$1.7 million in 2024.
• Biggest YoY gain for Change in Cash was 336.24% in 2021; the steepest drop was 185.5% in 2021.
• A 5-year view of Change in Cash shows it stood at -$8.5 million in 2021, then advanced by 17.78% to -$7.0 million in 2022, then soared by 78.11% to -$1.5 million in 2023, then surged by 123.42% to $360000.0 in 2024, then surged by 333.89% to $1.6 million in 2025.
• The last three Change in Cash figures came in at $1.6 million (Q3 2025), -$633000.0 (Q2 2025), and $407000.0 (Q1 2025), per Business Quant data.